(Q84808007)

English

Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: A simple model of prediction from a conservatively treated community‐based inception cohort

scientific article published on 01 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: A simple model of prediction from a conservatively treated community‐based inception cohort (English)

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

author name string

Xavier Le Loët

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Michel Brazier

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Othmane Mejjad

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Patrick Boumier

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Alain Daragon

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Alain Gayet

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sophie Pouplin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

François Tron

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Charles Zarnitsky

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Olivier Vittecoq

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jean-François Menard

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Patrice Fardellone

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20740612

23 June 2024

publication date

1 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acr.20321

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740612

23 June 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.20321

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

https://onlinelibrary.wiley.com/doi/full/10.1002/acr.20321

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Arthritis Care and Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

62

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1739-1747

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

2

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration

3

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies

4

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Treating rheumatoid arthritis early: a window of opportunity?

5

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention

6

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

8

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

9

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

10

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial

11

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis

12

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register

13

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

14

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.

15

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis

17

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria

18

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease

19

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial

20

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology

21

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

A prognostic index for erosive changes in the hands, feet, and cervical spines in early rheumatoid arthritis

22

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort.

23

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients

24

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Factors predicting outcome of rheumatoid arthritis: results of a followup study

25

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis

26

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis

27

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis

28

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Predictors of radiographic joint damage in patients with early rheumatoid arthritis

29

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Biomarkers in osteoarthritis

30

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Prognostic laboratory markers of joint damage in rheumatoid arthritis

31

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study

32

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis

33

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Serological bone markers and joint damage in early polyarthritis

35

1 reference

10.1002/ACR.20321

https://api.crossref.org/works/10.1002/ACR.20321

23 June 2024

Identifiers

10.1002/ACR.20321

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20740612%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84808007&oldid=2187265938"